{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T09:42:08Z","timestamp":1792662128825,"version":"4.5.0"},"reference-count":44,"publisher":"Public Library of Science (PLoS)","issue":"2","license":[{"start":{"date-parts":[[2014,2,4]],"date-time":"2014-02-04T00:00:00Z","timestamp":1391472000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0087923","type":"journal-article","created":{"date-parts":[[2014,2,4]],"date-time":"2014-02-04T22:12:49Z","timestamp":1391551969000},"page":"e87923","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":88,"title":["A Monoclonal Antibody TrkB Receptor Agonist as a Potential Therapeutic for Huntington\u2019s Disease"],"prefix":"10.1371","volume":"9","author":[{"given":"Daniel","family":"Todd","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian","family":"Gowers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon J.","family":"Dowler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael D.","family":"Wall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"McAllister","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David F.","family":"Fischer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sipke","family":"Dijkstra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvina A.","family":"Fratantoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rhea","family":"van de Bospoort","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Veenman-Koepke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geraldine","family":"Flynn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamshid","family":"Arjomand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Celia","family":"Dominguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ignacio","family":"Munoz-Sanjuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Wityak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan A.","family":"Bard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2014,2,4]]},"reference":[{"key":"ref1","first-page":"1267","article-title":"Huntington's disease. Pathogenesis and management","volume":"315","author":"JB Martin","year":"1986","journal-title":"N Engl J Med"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/B978-0-444-52014-2.00004-5","article-title":"Huntington's disease - neuropathology","volume":"100","author":"JP Vonsattel","year":"2011","journal-title":"Handb Clin Neurol"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/B978-0-444-52014-2.00003-3","article-title":"Molecular biology of Huntington's disease","volume":"100","author":"KN McFarland","year":"2011","journal-title":"Handb Clin Neurol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/B978-0-444-52014-2.00001-X","article-title":"Huntington's disease - clinical signs, symptoms, presymptomatic diagnosis, and diagnosis","volume":"100","author":"KM Shannon","year":"2011","journal-title":"Handb Clin Neurol"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/S0072-9752(07)01256-0","article-title":"Neuropathology of Huntington's disease","volume":"89","author":"JP Vonsattel","year":"2008","journal-title":"Handb Clin Neurol"},{"key":"ref6","first-page":"957","article-title":"Huntington's disease: a clinical, genetic and molecular model for polyglutamine repeat disorders","volume":"354","author":"PS Harper","year":"1999","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/0092-8674(93)90585-E","article-title":"A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes","volume":"72","year":"1993","journal-title":"Cell"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"5355","DOI":"10.1073\/pnas.91.12.5355","article-title":"Glutamine repeats as polar zippers: their possible role in inherited neurodegenerative diseases","volume":"91","author":"MF Perutz","year":"1994","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/S0092-8674(00)80514-0","article-title":"Huntingtin-encoded polyglutamine expansions form amyloid-like protein aggregates in vitro and in vivo","volume":"90","author":"E Scherzinger","year":"1997","journal-title":"Cell"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1126\/science.277.5334.1990","article-title":"Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain","volume":"277","author":"M DiFiglia","year":"1997","journal-title":"Science"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1038\/nature02998","article-title":"Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death","volume":"431","author":"M Arrasate","year":"2004","journal-title":"Nature"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/nature01301","article-title":"Pivotal role of oligomerization in expanded polyglutamine neurodegenerative disorders","volume":"421","author":"I S\u00e1nchez","year":"2003","journal-title":"Nature"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1002\/neu.480251107","article-title":"The Trk family of neurotrophin receptors","volume":"25","author":"M Barbacid","year":"1994","journal-title":"J Neurobiol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0079-6123(03)46002-0","article-title":"The p75 neurotrophin receptor: multiple interactors and numerous functions","volume":"146","author":"JJ Gentry","year":"2004","journal-title":"Prog Brain Res"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.tins.2012.03.007","article-title":"p75 neurotrophin receptor signaling in nervous system injury and degeneration: paradox and opportunity","volume":"35","author":"CF Ibanez","year":"2012","journal-title":"Trends Neurosci"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"59","DOI":"10.2174\/1568007023339490","article-title":"Small molecule Trk receptor agonists and other neurotrophic factor mimetics","volume":"1","author":"SJ Pollack","year":"2002","journal-title":"Curr Drug Targets CNS Neurol Disord"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1111\/j.1460-9568.2006.04590.x","article-title":"Reduced expression of the TrkB receptor in Huntington's disease mouse models and in human brain","volume":"23","author":"S Gines","year":"2006","journal-title":"Eur J Neurosci"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/j.1750-3639.2007.00111.x","article-title":"Systematic assessment of BDNF and its receptor levels in human cortices affected by Huntington's disease","volume":"18","author":"C Zuccato","year":"2008","journal-title":"Brain Pathol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1126\/science.1059581","article-title":"Loss of huntingtin-mediated BDNF gene transcription in Huntington's disease","volume":"293","author":"C Zuccato","year":"2001","journal-title":"Science"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"11758","DOI":"10.1523\/JNEUROSCI.2461-07.2007","article-title":"Expression profiling of Huntington's disease models suggests that brain-derived neurotrophic factor depletion plays a major role in striatal degeneration","volume":"27","author":"AD Strand","year":"2007","journal-title":"J Neurosci"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"14708","DOI":"10.1523\/JNEUROSCI.1637-10.2010","article-title":"BDNF overexpression in the forebrain rescues Huntington's disease phenotypes in YAC128 mice","volume":"30","author":"Y Xie","year":"2010","journal-title":"J Neurosci"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1212\/WNL.52.7.1427","article-title":"A controlled trial of recombinant methionyl human BDNF in ALS","volume":"52","year":"1999","journal-title":"Neurology"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1038\/nrd4024","article-title":"Small-molecule modulation of neurotrophin receptors: a strategy for the treatment of neurological disease","volume":"12","author":"FM Longo","year":"2013","journal-title":"Nat Rev Drug Discov"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"e1900","DOI":"10.1371\/journal.pone.0001900","article-title":"Appetite enhancement and weight gain by peripheral administration of TrkB agonists in non-human primates","volume":"3","author":"JC Lin","year":"2008","journal-title":"PLoS ONE"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"9394","DOI":"10.1523\/JNEUROSCI.1118-06.2006","article-title":"Novel Agonist Monoclonal Antibodies Activate TrkB Receptors and Demonstrate Potent Neurotrophic Activities","volume":"26","author":"MD Qian","year":"2006","journal-title":"The Journal of Neuroscience"},{"key":"ref26","unstructured":"Boyden TL, Guo F, Lagreca SD, Lorenz DA, Shanker RM, et al. (2007) Salts, prodrugs and formulations of 1-(5-(4-amino-7-isopropyl-7H-pyrrolo[2,3-d]pyrimidine-5-carbonyl)-2-methoxyphenyl)-3-(2,4-dichlorophenyl)urea. In: Organization WIP, editor."},{"key":"ref27","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1046\/j.1471-4159.2000.0750991.x","article-title":"Sequential Treatment of SH-SY5Y Cells with Retinoic Acid and Brain-Derived Neurotrophic Factor Gives Rise to Fully Differentiated, Neurotrophic Factor-Dependent, Human Neuron-Like Cells","volume":"75","author":"M Encinas","year":"2000","journal-title":"J Neurochem"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1177\/1087057110373392","article-title":"Composite primary neuronal high-content screening assay for Huntington's disease incorporating non-cell-autonomous interactions","volume":"15","author":"LS Kaltenbach","year":"2010","journal-title":"J Biomol Screen"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"27","DOI":"10.2174\/1875397300801010027","article-title":"Cellular assays for high-throughput screening for modulators of Trk receptor tyrosine kinases","volume":"1","author":"J Wang","year":"2008","journal-title":"Curr Chem Genomics"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"8125","DOI":"10.1523\/JNEUROSCI.23-22-08125.2003","article-title":"Brain-derived neurotrophic factor activation of NFAT (nuclear factor of activated T-cells)-dependent transcription: a role for the transcription factor NFATc4 in neurotrophin-mediated gene expression","volume":"23","author":"RD Groth","year":"2003","journal-title":"J Neurosci"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1111\/j.1476-5381.2010.01094.x","article-title":"Pharmacological characterization of six trkB antibodies reveals a novel class of functional agents for the study of the BDNF receptor","volume":"162","author":"M Cazorla","year":"2011","journal-title":"Br J Pharmacol"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.stem.2012.04.027","article-title":"Induced Pluripotent Stem Cells from Patients with Huntington's Disease Show CAG-Repeat-Expansion-Associated Phenotypes","volume":"11","author":"T HD iPSC Consortium","year":"2012","journal-title":"Cell Stem Cell"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/j.chembiol.2009.05.010","article-title":"The antidepressant amitriptyline is a TrkA and TrkB receptor agonist that promotes TrkA\/TrkB heterodimerization and has potent neurotrophic activity","volume":"16","author":"SW Jang","year":"2009","journal-title":"Chem Biol"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1016\/S0022-3565(24)37161-7","article-title":"Neurotransmitter receptor and transporter binding profile of antidepressants and their metabolites","volume":"283","author":"MJ Owens","year":"1997","journal-title":"J Pharmacol Exp Ther"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"3876","DOI":"10.1073\/pnas.0912531107","article-title":"N-acetylserotonin activates TrkB receptor in a circadian rhythm","volume":"107","author":"SW Jang","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"2687","DOI":"10.1073\/pnas.0913572107","article-title":"A selective TrkB agonist with potent neurotrophic activities by 7,8-dihydroxyflavone","volume":"107","author":"SW Jang","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"8524","DOI":"10.1021\/jm301099x","article-title":"Optimization of a small tropomyosin-related kinase B (TrkB) agonist 7,8-dihydroxyflavone active in mouse models of depression","volume":"55","author":"X Liu","year":"2012","journal-title":"J Med Chem"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1172\/JCI41356","article-title":"Small molecule BDNF mimetics activate TrkB signaling and prevent neuronal degeneration in rodents","volume":"120","author":"SM Massa","year":"2010","journal-title":"J Clin Invest"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"5862","DOI":"10.1074\/jbc.M411121200","article-title":"Overcoming the inhibitors of myelin with a novel neurotrophin strategy","volume":"280","author":"G Williams","year":"2005","journal-title":"J Biol Chem"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1080\/14660820050515197","article-title":"A phase I\/II trial of recombinant methionyl human brain derived neurotrophic factor administered by intrathecal infusion to patients with amyotrophic lateral sclerosis","volume":"1","author":"G Ochs","year":"2000","journal-title":"Amyotrophic Lateral Sclerosis"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1146\/annurev.biochem.72.121801.161629","article-title":"Trk receptors: roles in neuronal signal transduction","volume":"72","author":"EJ Huang","year":"2003","journal-title":"Annu Rev Biochem"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.neulet.2011.05.054","article-title":"Antioxidant activity of 7,8-dihydroxyflavone provides neuroprotection against glutamate-induced toxicity","volume":"499","author":"J Chen","year":"2011","journal-title":"Neurosci Lett"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"2462","DOI":"10.1093\/hmg\/ddt098","article-title":"Small-molecule TrkB receptor agonists improve motor function and extend survival in a mouse model of Huntington's disease","volume":"22","author":"M Jiang","year":"2013","journal-title":"Hum Mol Genet"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"e64037","DOI":"10.1371\/journal.pone.0064037","article-title":"Systemic delivery of recombinant brain derived neurotrophic factor (BDNF) in the R6\/2 mouse model of Huntington's disease","volume":"8","author":"C Giampa","year":"2013","journal-title":"PLoS One"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0087923","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T19:30:51Z","timestamp":1746127851000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0087923"}},"subtitle":[],"editor":[{"given":"Michal","family":"Hetman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2014,2,4]]},"references-count":44,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2014,2,4]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0087923","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,2,4]]}}}